Thursday, November 13, 2025

CATEGORY

General

EMA Enhances System Demos with New Digital Platforms and User Engagement

The European Medicines Agency (EMA) conducted its fourth system demonstration of 2025, highlighting its consistent advancement in the digital landscape to better serve its...

Collegium Reports Bullish Q3 2025 Growth with Increased Revenue and Guidance Boost

Collegium Pharmaceutical is riding a wave of robust growth, closing the third quarter of 2025 with exceptional financial results. The company revealed a striking...

Ambu Aims for Dominance in Global Endoscopy with Strategic Initiative

Amidst dynamic and challenging global landscapes, Ambu A/S has reported formidable financial outcomes for FY 2024/25. With geopolitical tensions swirling and macroeconomic factors at...

Anika Amplifies Revenue through Robust Commercial Growth and Strategic Advancements

In the rapidly evolving orthopedic industry, Anika Therapeutics has solidified its presence with impressive growth markers in its latest report. The company doesn’t just...

EMA Passes ICMRA Leadership Torch to Australia’s Anthony Lawler

The realm of international medicines regulation witnessed a pivotal moment at the recent ICMRA Summit 2025 held in Amsterdam. With the conclusion of Emer...

Roche Reports Robust Third Quarter Sales for 2025

Global pharmaceutical giant F. Hoffmann-La Roche Ltd. has reported its financial performance for the third quarter of 2025, showcasing a growth trajectory amid evolving...

Merck Showcases Groundbreaking Cardio-Pulmonary Research at AHA 2025

Amid growing concerns about cardiovascular diseases, Merck propels its research momentum at the American Heart Association (AHA) Scientific Sessions 2025, delivering pivotal insights into...

MIDBA: Revolutionizing Drug Delivery with YpsoMate

The Molecule Independent Device Bridging Approach (MIDBA) with YpsoMate represents a significant milestone in drug delivery innovations. Unlike traditional methodologies, MIDBA opts for an...

BioMarin Sets Date for Q3 Financial Reveals and Company Outlook

BioMarin Pharmaceutical Inc. continues to play a pivotal role in biotechnology, spearheading the creation of innovative medicines aimed at rare genetic disorders. The upcoming...

Diacomit: A Hopeful Development for Severe Myoclonic Epilepsy

Dravet Syndrome, a severe form of childhood epilepsy, triggers a desperate search for effective treatments. Among these is Diacomit, an anti-epileptic drug showing promise...

G-BA Assigns IQWiG to Probe Links Between Surgery Volume and Quality in Pediatric Anorectal Malformations

The complexities surrounding the connection between the volume of medical procedures and the resulting quality of care are progressively emerging as significant concerns in...

New Clinical Trials Information System Enhances Data Transparency

Clinical trials form the backbone of medical advancement, offering a systematic means for evaluating treatments and improving patient care. With the evolution of modern...

CSL Seqirus Spotlights Advanced Flu Vaccine Innovations at ESWI Congress

CSL Seqirus is making a significant impact at the European Scientific Working group on Influenza (ESWI) conference, a much-anticipated gathering for experts across the...

Rising Disparities in Hip Fracture Readmissions

The landscape of healthcare delivery concerning hip fracture care reveals significant disparities influenced by racial and socioeconomic factors. This study sheds light on the...

Spain Boosts R&D Workforce with New Funding for Technical Staff

Spain is setting the stage to enhance its research and development (R&D) capabilities by offering new financial support dedicated to technical personnel in R&D...

Latest news